Shigella flexneri 2a Invaplex 50 vaccine dose finding and assessment of protection

Trial Profile

Shigella flexneri 2a Invaplex 50 vaccine dose finding and assessment of protection

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Jul 2011

At a glance

  • Drugs Shigella flexneri 2A vaccine (Primary)
  • Indications Diarrhoea; Dysentery; Fever; Shigella infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Jul 2011 Results published in Vaccine.
    • 01 Dec 2010 Planned end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Actual initiation date (May 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top